ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Institute of Medicine Elects 80 New Members

October 24, 2014

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

Construction Report Scheduled for NCAB

August 25, 1978

In Brief: White House Conservative Said Seeking Ouster Of Schweiker; Potter urges Greater Commitment

November 26, 1982

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982